000 01019 a2200313 4500
005 20250514020652.0
264 0 _c20021010
008 200210s 0 0 eng d
022 _a0277-6715
024 7 _a10.1002/sim.1018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWillan, A R
245 0 0 _aCost-effectiveness analysis when the WTA is greater than the WTP.
_h[electronic resource]
260 _bStatistics in medicine
_cNov 2001
300 _a3251-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBayes Theorem
650 0 4 _aBiometry
650 0 4 _aClinical Trials as Topic
_xeconomics
650 0 4 _aCost-Benefit Analysis
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPalliative Care
_xeconomics
650 0 4 _aProstatic Neoplasms
_xdrug therapy
700 1 _aO'Brien, B J
700 1 _aLeyva, R A
773 0 _tStatistics in medicine
_gvol. 20
_gno. 21
_gp. 3251-9
856 4 0 _uhttps://doi.org/10.1002/sim.1018
_zAvailable from publisher's website
999 _c11659285
_d11659285